1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

About 7000 reports for Lymphoma (page 4)

Purchase Reports From Reputable Market Research Publishers

Hodgkin’s Lymphoma - Opportunity Analysis and Forecasts to 2029

  • $ 10995
  • June 2020
  • 140 pages

M. (2019) CANCER, LYMPHOMA, HODGKIN, STATPEARLS.

  • Cancer
  • Chemotherapy
  • Lymphoma
  • Therapy
  • Forecast

ASIA PACIFIC AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET FORECAST 2019-2027

  • $ 1250
  • August 2019
  • 92 pages

LYMPHOMA IN THE UNITED STATES 2019 (%) FIGURE ## ASIA PACIFIC AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET SHARE BY PRODUCT TYPE 2018 & 2027 (%) FIGURE ## ASIA PACIFIC AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY DEVICES, 2019-2027 ($ MILLION) FIGURE ## ASIA PACIFIC AUTOTRANSFUSION

  • Healthcare
  • Lymphoma
  • APAC

Global Hematology Partnering 2010-2020: Deal trends, players and financials

  • $ 3495
  • June 2020
  • 400 pages

Lymphoma Research, Leukemia & Lymphoma Society, Lev Pharmaceuticals, LFB Biomedicaments, LFB Biotechnologies, LifeHealth, Ligand Pharmaceuticals, Lonza, Loop Medical, LUNAC Therapeutics, Mallinckrodt Pharmaceuticals, MannKind Biopharmaceuticals, Mantecorp, Maruho, Masimo, Massa

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States
  • Demand

Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2024

  • $ 2800
  • November 2018
  • 400 pages

Global CAR T-Cell Therapy - Clinical Trials for Cancer Treatment ##. ## Acute Lymphoblastic Leukemia ##. ## Multiple Myeloma ##. ## Brain Tumors ##. ## Lymphoma ##. ## Solid Tumors ##.

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy

B-cell Non-Hodgkin’s Lymphoma—Market Insights, Epidemiology, and Market Forecast—2028

  • $ 6250
  • January 2020
  • 287 pages

Burkitt Lymphoma ##. ##. ##.

  • Cancer
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • United States

NHL: Follicular lymphoma

  • $ 5000
  • April 2016
  • 252 pages

NHL: Follicular lymphoma Disease Coverage | Treatment: Follicular Lymphoma practices.

  • Cancer
  • Healthcare
  • Lymphoma
  • Monoclonal Antibody
  • Therapy

NHL: Mantle cell lymphoma

  • $ 5000
  • April 2016
  • 214 pages

Lymphoma Association (2016) Mantle cell lymphoma.

  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy

Cancer Cell Analysis, Instruments, Consumables and Reagents

  • $ 5500
  • December 2018
  • 235 pages

Lymphoma, and Myeloma, 2018 Figure ## : Basic Components of a Spectrophotometer Figure ## : Classification of Cell Microarrays Figure ## : Key Application of Quantitative PCR or Real-Time PCR Figure ## : End-User Segmentation Figure ## : Workflow for Gene Expression Figure ## : Prevalence of

  • Cancer
  • Lymphoma
  • Medical Biotechnology
  • Pathology
  • World

T-Cell Therapy Market Size, Share & Trends Analysis Report By Modality, By Therapy, By Indication And Segment Forecasts, 2019 - 2026

  • $ 5950
  • September 2019
  • 200 pages

lymphoma and acute lymphocytic leukemia has resulted in the dominance of hematological malignancies in the market • Therapy for solid tumors is expected to emerge as the lucrative source of revenue generation in the forthcoming years • Rising research activities in CAR T-cell therapy for so

  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • United States
  • Market Size

CAR-T Therapies Market (2nd Edition), 2019-2030

  • $ 3999
  • August 2019
  • 580 pages

Leukemia and Lymphoma ##. ##. ##. ##.

  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • United States

Global Nuclear Medicine Market Analysis & Trends - Industry Forecast to 2027

  • $ 4200
  • October 2018
  • 184 pages

Therapeutic application is segmented into lymphoma, thyroid, endocrine tumor, bone metastasis and other therapeutic application.

  • Cancer
  • Lymphoma
  • United States
  • World
  • Forecast

Global Diagnostics Partnering Terms and Agreements 2014-2020

  • $ 3495
  • May 2020
  • 1000 pages

Lymphoma Society, LG Life Sciences, Lonza, Lumos Pharma, Lupagen, MAB Discovery, Mabion, MabVax Therapeutics, mAbXience, Macquarie University, Macrogenics, Mapp Biopharmaceutical, Massachusetts General Hospital, Mayo Clinic, MD Anderson Cancer Center, MedImmune, Medison Pharma, Medivation,

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • United States

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020

  • $ 3495
  • May 2020
  • 300 pages

Hussman Foundation, Johns Hopkins University, Johnson & Johnson Innovation, JSC Binnopharm, JSC Pharmadis, Juvaris BioTherapeutics, KAEL-GemVax, KellBenx, Kindred Bio, Leukaemia & Lymphoma Research, LG Life Sciences, Ligand Pharmaceuticals, Lineage Cell Therapeutics, LineaRx, London

  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • United States

Cell Line and Membrane Market

  • $ 5500
  • March 2019
  • 176 pages

Lymphoma, and Myeloma, 2018 Table ## : Global Forensic Testing Market, by Region, Through 2023 Table ## : Current Status of SNP, STR, and DNA Barcode Technologies as Standard Methods for Assessing the Identity of Cell Lines from Different Species Table ## : Global Tissue Engineering Market,

  • Cell Therapy
  • Lymphoma
  • Medical Biotechnology
  • World

Kinenza

  • $ 10000
  • October 2018
  • 17 pages

Kinenza CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Kinenza : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Kinenza for diffuse large B-cell lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary for Kinen

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • United States

MOR208

  • $ 10000
  • October 2018
  • 17 pages

MOR## CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## MOR## : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: MOR## for diffuse large B-cell lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary for MOR## i

  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • United States

polatuzumab vedotin

  • $ 10000
  • October 2018
  • 18 pages

polatuzumab vedotin CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## polatuzumab vedotin : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Polatuzumab vedotin for diffuse large B-cell lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’

  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy

Global Cancer Immunotherapy Market Analysis & Forecast to 2023

  • $ 4900
  • January 2020
  • 450 pages

Lymphoma ##. ##. ## Therapeutic Vaccines in Development for Lymphoma ##. ##. ## Checkpoint Inhibitors for Lymphoma ##. ##. ## Adoptive T Cell Transfer for Lymphoma ##. ##. ## Monoclonal Antibodies for Lymphoma ##. ## Immunotherapy for Kidney Cancer ##. ##. ## Checkpoint Inhibitors f

  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • World

Global Cancer Diagnostics Partnering Terms and Agreements 2014-2020

  • $ 3495
  • May 2020
  • 450 pages

Lymphoma Research, Leukocare, LG Life Sciences, LineaRx, Los Angeles Biomedical Research Institute, Louisiana State University, Lumos Pharma, Lund University, Lung Cancer Research Foundation, MabVax Therapeutics, Madison Vaccines, Massachusetts General Hospital, Matrivax, Mayo Clinic, MBF T

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Vaccine
  • United States
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on